Sort by
Refine Your Search
-
Listed
-
Program
-
Field
-
of Competence in Research (NCCR) AntiResist . We develop and use state-of-the-art organoid technology to better understand human infections and foster antibiotic discovery. We conduct a wide range of assays
-
Your position The project aims to develop novel anti-biofilm compounds that can be used to treat biofilm-related infections caused by a range of bacterial pathogens. Based on structural data
-
discovery and development through in vitro modelling of in-patient conditions in order to address antibiotic resistance, a problem of global importance. To reach this goal, AntiResist has assembled a panel of
-
at the interface of bacterial signal transduction and phage biology. Our research group at the Biozentrum is embedded in the National Centre of Competence in Research (NCCR) AntiResist. We develop and use state
-
disease and to develop pioneering therapies benefiting the lives of patients in areas of unmet need. With more than 70 research groups and 800 employees, the Department of Biomedicine is the largest
-
develop new therapies for vision loss. It is a place where your expertise will be valued, your abilities challenged, and your knowledge expanded. Position Overview We are seeking a motivated Research
-
before 1800. Candidates are conversant with current historiographical developments and have developed strong methodological skills in dealing with different source corpora of African history. We expect
-
the National Centre of Competence in Research (NCCR) AntiResist. We develop and use state-of-the-art organoid technology to better understand human infections and foster antibiotic discovery. We conduct a wide
-
to solve fundamental questions surrounding evolution and interaction between bacteria and bacteriophages. The Biozentrum provides a highly stimulating collaborative research environment with a
-
the interaction and co-evolution between bacteria and a family of large bacterial viruses, called jumbophages. We are particularly interested in how bacteria use immune systems to antagonize jumbophage infection